Drug intelligence / Profile preview

6-{4-[hydroxy-(4-nitro-phenoxy)-phosphoryl]-butyrylamino}-hexanoic acid

Development stage
Unknown
Modality
Small Molecules
01

Overview

This compound is a small molecule experimental drug classified chemically as a nitrobenzene derivative containing a phosphoryl group linked to hydroxy and nitrophenoxy moieties. It has the molecular formula C16H23N2O8P and an average molecular weight of approximately 402.34 g/mol. There is no available information on its mechanism of action, therapeutic indications, or clinical use. It is not approved for any medical condition and has no recorded patents or marketed brand names. The drug appears to be in an early stage of research with no clinical trials reported beyond phase 0 or preclinical status.[1][2][3][4]

Other names
6-({4-[Hydroxy(4-nitrophenoxy)phosphoryl]butanoyl}amino)hexanoic acid6-{4-[hydroxy-(4-nitrophenoxy)phosphoryl]butyrylamino}hexanoic acidHexanoic acid, 6-[[4-[hydroxy(4-nitrophenoxy)phosphinyl]-1-oxobutyl]amino]-

Beyond the preview

Go deeper on 6-{4-[hydroxy-(4-nitro-phenoxy)-phosphoryl]-butyrylamino}-hexanoic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 6-{4-[hydroxy-(4-nitro-phenoxy)-phosphoryl]-butyrylamino}-hexanoic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call